Drugs: Prices

(asked on 23rd January 2023) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the impact of the NHS continuing to adopt uniform pricing by medicine on patient access to innovative medicines.


Answered by
Will Quince Portrait
Will Quince
This question was answered on 30th January 2023

No assessment has been made. NHS England set out their commercial approach to new medicines in the Commercial Framework published in February 2021. The framework sets out, in line with commitments made under the Voluntary scheme for branded medicines pricing and access (VPAS), that the National Health Service can reach complex confidential commercial arrangements with companies that bring new medicines to the market which offer greater levels of health gain relative to cost. The commercial framework allows the flexibility to create different commercial approaches where the importance of the medicine warrants it.

Reticulating Splines